NewGenIvf Group (NIVF) Financial Statements
NewGenIvf Group Financial Overview
NewGenIvf Group's market cap is currently $1.21M. The company's EPS TTM is $-6.61; its P/E ratio is 0.00; NewGenIvf Group has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.73M | $ 5.43M | $ 5.14M | $ 5.94M | $ 4.12M |
| Gross Profit | $ 955.85K | $ 1.83M | $ 1.68M | $ 1.54M | $ 1.02M |
| Operating Income | $ -10.73M | $ -1.16M | $ 42.24K | $ 398.70K | $ 198.76K |
| EBITDA | $ 10.84M | $ 24.26K | $ 384.31K | $ 725.69K | $ 587.01K |
| Net Income | $ 9.88M | $ -525.00K | $ 130.19K | $ 458.67K | $ -533.00 |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 758.62K | $ 457.74K | $ 54.10K | $ 27.56K | $ 28.76K |
| Total Assets | $ 32.72M | $ 3.58M | $ 4.49M | $ 2.90M | $ 1.41M |
| Total Debt | $ 4.86M | $ 3.03M | $ 332.55K | $ 452.04K | $ 925.97K |
| Net Debt | $ 4.11M | $ 2.57M | $ 278.45K | $ 424.49K | $ 897.20K |
| Total Liabilities | $ 6.74M | $ 5.06M | $ 1.24M | $ 2.80M | $ 2.33M |
| Stockholders' Equity | $ 26.63M | $ -1.05M | $ 3.74M | $ 563.11K | $ -775.94K |
| Cash Flow | |||||
| Free Cash Flow | $ -16.68M | $ -8.32M | $ -1.86M | $ -621.58K | $ 1.42M |
| Operating Cash Flow | $ -10.93M | $ -8.26M | $ -1.79M | $ -527.12K | $ 1.43M |
| Investing Cash Flow | $ -7.56M | $ -53.05K | $ -69.85K | $ -69.69M | $ -16.57K |
| Financing Cash Flow | $ 18.99M | $ 8.68M | $ 1.91M | $ 70.27M | $ -1.54M |
Currency in USD